Cargando…

Interleukin-33 as a Potential Therapeutic Target for Interstitial Cystitis: New Perspectives on Mast Cell Regulation

Detalles Bibliográficos
Autor principal:	Choo, Min Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Continence Society 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582083/ https://www.ncbi.nlm.nih.gov/pubmed/26620893 http://dx.doi.org/10.5213/inj.2015.19.3.132

Ejemplares similares

Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis
por: Park, Chang-Shin, et al.
Publicado: (2011)

New Insights into the Mechanism of the Down-Regulation of Mast Cells in the Treatment of Interstitial Cystitis: Possible Role of Siglecs
por: Lee, Tack
Publicado: (2011)

The importance of mast cells in interstitial cystitis/bladder pain syndrome
por: Ratner, Vicki
Publicado: (2016)

Therapeutic effects of axitinib, an anti-angiogenic tyrosine kinase inhibitor, on interstitial cystitis
por: Shin, Jung Hyun, et al.
Publicado: (2023)

Potential Use of Antiproliferative Factor as a Targeting Therapy in Painful Bladder Syndrome/Interstitial Cystitis
por: Kim, Khae Hawn
Publicado: (2011)

Animal Model of Interstitial Cystitis/Bladder Pain Syndrome
por: Kwon, Whi-An
Publicado: (2018)

Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist’s Perspective
por: Jang, Tae Young, et al.
Publicado: (2015)

Interstitial Cystitis/Bladder Pain Syndrome: A Urologic Mystery
por: Cho, Young Sam
Publicado: (2016)

Mast cell activation syndrome in pain syndromes bladder pain syndrome/interstitial cystitis and vulvodynia
por: Regauer, Sigrid
Publicado: (2016)

Human Umbilical Cord Mesenchymal Stem Cell Therapy Mitigates Interstitial Cystitis by Inhibiting Mast Cells
por: Xu, Yuancheng, et al.
Publicado: (2021)

Elimination of Hunner's Ulcers by Fulguration in Patients With Interstitial Cystitis: Is It Effective and Long Lasting?
por: Ryu, Jeman, et al.
Publicado: (2013)

Bruton tyrosine kinase (BTK) may be a potential therapeutic target for interstitial cystitis/bladder pain syndrome
por: Wang, Guang, et al.
Publicado: (2022)

Editorial: Special Issue “Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)”
por: Neuhaus, Jochen, et al.
Publicado: (2022)

Co-Morbidities of Interstitial Cystitis
por: Chelimsky, Gisela, et al.
Publicado: (2012)

Interstitial cystitis intravesical therapy
por: Ha, Tanya, et al.
Publicado: (2017)

Development of the Interstitial Cystitis Self-Help and Medical Resources Scale (ICSR) for Women with Interstitial Cystitis
por: Chen, Hui-Chun, et al.
Publicado: (2022)

To reveal pharmacological targets and molecular mechanisms of curcumol against interstitial cystitis
por: Wu, Ka, et al.
Publicado: (2019)

A high molecular weight hyaluronic acid biphasic dispersion as potential therapeutics for interstitial cystitis
por: Rooney, Peadar R., et al.
Publicado: (2020)

Interleukin-33 Primes Mast Cells for Activation by IgG Immune Complexes
por: Kaieda, Shinjiro, et al.
Publicado: (2012)

Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins
por: West, Peter W., et al.
Publicado: (2021)

Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome
por: Ueda, Tomohiro, et al.
Publicado: (2021)

Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights
por: Chatterjee, Annesha, et al.
Publicado: (2023)

Pretreatment Features to Influence Effectiveness of Intravesical Hyaluronic Acid Instillation in Refractory Interstitial Cystitis/Painful Bladder Syndrome
por: Kim, Aram, et al.
Publicado: (2014)

A new player in interstitial cystitis/bladder pain syndrome: platelet‐activating factor – PAF and its connection to smoking
por: Kullmann, Florenta Aura
Publicado: (2017)

Current guidelines in the management of interstitial cystitis
por: Colaco, Marc, et al.
Publicado: (2015)

How does interstitial cystitis begin?
por: Parsons, C. Lowell
Publicado: (2015)

An update on treatment options for interstitial cystitis
por: Garzon, Simone, et al.
Publicado: (2020)

Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis
por: Kato, Toru, et al.
Publicado: (2019)

Mast Cell-Derived Histamine Mediates Cystitis Pain
por: Rudick, Charles N., et al.
Publicado: (2008)

Non-Hunner's Interstitial Cystitis Is Different from Hunner's Interstitial Cystitis and May Be Curable by Uterosacral Ligament Repair
por: Goeschen, Klaus, et al.
Publicado: (2022)

Synergistic Effects of N-Acetylcysteine and Mesenchymal Stem Cell in a Lipopolysaccharide-Induced Interstitial Cystitis Rat Model
por: Shin, Jung Hyun, et al.
Publicado: (2019)

The Use of Urine Proteomic and Metabonomic Patterns for the Diagnosis of Interstitial Cystitis and Bacterial Cystitis
por: Van, Que N., et al.
Publicado: (2004)

The study on the function and cell source of interleukin‐6 in interstitial cystitis/bladder painful syndrome rat model
por: Zheng, Zhenming, et al.
Publicado: (2021)

Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment
por: Kim, Aram, et al.
Publicado: (2017)

Application of Adult and Pluripotent Stem Cells in Interstitial Cystitis/Bladder Pain Syndrome Therapy: Methods and Perspectives
por: Abdal Dayem, Ahmed, et al.
Publicado: (2020)

From interstitial cystitis to chronic pelvic pain
por: Persu, C, et al.
Publicado: (2010)

Metabolomics Insights Into Pathophysiological Mechanisms of Interstitial Cystitis
por: Fiehn, Oliver, et al.
Publicado: (2014)

Recent advances in imaging and understanding interstitial cystitis
por: Tyagi, Pradeep, et al.
Publicado: (2018)

Interstitial cystitis: an enigmatic disorder of unclear aetiology
por: Moutzouris, Dimitrios-Anestis, et al.
Publicado: (2008)

Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis
por: Mykoniatis, Ioannis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vvd5j105dik3rq6ecq8s0q4j51